Boston Scientific (BSX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.17 Bn | 17.76 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.45% |
| Mar 31, 2026 | 32.61% |
| Dec 31, 2025 | 27.94% |
| Sep 30, 2025 | 45.26% |
| Jun 30, 2025 | 48.45% |
| Mar 31, 2025 | 127.75% |
| Dec 31, 2024 | -32.38% |
| Sep 30, 2024 | 30.07% |
| Jun 30, 2024 | 16.04% |
| Mar 31, 2024 | 3.14% |
| Dec 31, 2023 | 5.52% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | -14.04% |
| Mar 31, 2023 | 0.20% |
| Dec 31, 2022 | 17.14% |
| Sep 30, 2022 | -9.27% |
| Jun 30, 2022 | 11.00% |
| Mar 31, 2022 | -19.67% |
| Dec 31, 2021 | -8.39% |
| Sep 30, 2021 | 12.18% |